Literature DB >> 20972594

18F-FDG PET as a diagnostic procedure in large vessel vasculitis-a controlled, blinded re-examination of routine PET scans.

Petra Lehmann1, Sarah Buchtala, Nelli Achajew, Peter Haerle, Boris Ehrenstein, Hamid Lighvani, Martin Fleck, Joerg Marienhagen.   

Abstract

Large vessel vasculitis can be visualized by 18F-FDG positron emission tomography (PET). However, the diagnostic value of 18F-FDG PET is yet to be determined. We therefore performed a study to evaluate this technique for the diagnosis of giant cell arteritis (GCA) and Takayasu arteritis (TA). Patients with GCA or TA, who fulfilled the American College of Rheumatology (ACR) criteria and also had a pathologic PET scan in clinical routine, were selected. These PET scans, as well as PET scans obtained from age- and sex-matched control patients, were independently re-evaluated by two experienced nuclear medicine experts. PET scans of 20 patients (17 GCA, 3 TA) and 20 controls were evaluated. In 85% of the examinations, both observers agreed on the diagnosis or exclusion of vasculitis. Specificity was calculated with 80% and sensitivity with 65%, yielding an overall diagnostic accuracy of 72%. The mean maximum standardized uptake values (SUVmax) of the subclavian region was significantly higher in vasculitis than in control patients (2.77 ± 1.02 vs 2.09 ± 0.64; difference 0.69; CI(95%): 0.14-1.24, p = 0.0161). SUVmax of the iliacal regions did not differ significantly. Receiver- operating characteristics (ROC) analysis revealed the highest sensitivity of 90% (CI(95%): 68-99%) and specificity of 45% (CI(95%): 23-69%) for a SUVmax cut-off point of 1.78 (AUC 0.72, (CI(95%): 0.56-0.86). PET findings are reproducible and independent of the observer. The low sensitivity and specificity indicate that enhanced vascular uptake might be overrated if clinical details are suggestive for vasculitis. Therefore, the diagnosis of large vessel vasculitis should not be based on PET findings only.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20972594     DOI: 10.1007/s10067-010-1598-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  23 in total

1.  Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch.

Authors:  D Blockmans; S Stroobants; A Maes; L Mortelmans
Journal:  Am J Med       Date:  2000-02-15       Impact factor: 4.965

2.  Non-invasive imaging in the diagnosis and management of Takayasu's arteritis.

Authors:  J Andrews; A Al-Nahhas; D J Pennell; M S Hossain; K A Davies; D O Haskard; J C Mason
Journal:  Ann Rheum Dis       Date:  2004-08       Impact factor: 19.103

3.  18F-fluorodeoxyglucose positron emission tomography/computed tomography findings in a patient with human immunodeficiency virus-associated Castleman's disease and Kaposi sarcoma, disorders associated with human herpes virus 8 infection.

Authors:  Francesco Bertagna; Giorgio Biasiotto; Rosita Rodella; Raffaele Giubbini; Abass Alavi
Journal:  Jpn J Radiol       Date:  2010-05-01       Impact factor: 2.374

4.  Aortic wall inflammation due to Takayasu arteritis imaged with 18F-FDG PET coregistered with enhanced CT.

Authors:  Yasushi Kobayashi; Kenji Ishii; Keiichi Oda; Tadashi Nariai; Youji Tanaka; Kiichi Ishiwata; Fujio Numano
Journal:  J Nucl Med       Date:  2005-06       Impact factor: 10.057

5.  Assessment of large-vessel involvement in giant cell arteritis with 18F-FDG PET: introducing an ROC-analysis-based cutoff ratio.

Authors:  Hubertus Hautzel; Oliver Sander; Alexander Heinzel; Matthias Schneider; Hans-Wilhelm Müller
Journal:  J Nucl Med       Date:  2008-06-13       Impact factor: 10.057

6.  The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis.

Authors:  W P Arend; B A Michel; D A Bloch; G G Hunder; L H Calabrese; S M Edworthy; A S Fauci; R Y Leavitt; J T Lie; R W Lightfoot
Journal:  Arthritis Rheum       Date:  1990-08

7.  [18FDG-PET and large vessel vasculitis: preliminary data on 25 patients].

Authors:  M Bruschi; F De Leonardis; M Govoni; M Roncali; N Prandini; R La Corte; L Feggi; F Trotta
Journal:  Reumatismo       Date:  2008 Jul-Sep

8.  [18F] FDG-PET/CT as a new and sensitive imaging method for the diagnosis of large vessel vasculitis.

Authors:  J C Henes; M Müller; J Krieger; B Balletshofer; A C Pfannenberg; L Kanz; I Kötter
Journal:  Clin Exp Rheumatol       Date:  2008 May-Jun       Impact factor: 4.473

9.  Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations.

Authors:  James H F Rudd; Kelly S Myers; Sameer Bansilal; Josef Machac; Cathy Anne Pinto; Christopher Tong; Ash Rafique; Richard Hargeaves; Michael Farkouh; Valentin Fuster; Zahi A Fayad
Journal:  J Nucl Med       Date:  2008-05-15       Impact factor: 10.057

10.  Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients.

Authors:  Daniël Blockmans; Liesbet de Ceuninck; Steven Vanderschueren; Daniël Knockaert; Luc Mortelmans; Herman Bobbaers
Journal:  Arthritis Rheum       Date:  2006-02-15
View more
  31 in total

Review 1.  Recent advances in diagnostic strategies for giant cell arteritis.

Authors:  Tanaz A Kermani; Kenneth J Warrington
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

Review 2.  Usefulness of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography in patients with large-vessel vasculitis: a systematic review.

Authors:  Giorgio Treglia; Maria Vittoria Mattoli; Lucia Leccisotti; Gianfranco Ferraccioli; Alessandro Giordano
Journal:  Clin Rheumatol       Date:  2011-08-11       Impact factor: 2.980

3.  Towards an optimal semiquantitative approach in giant cell arteritis: an (18)F-FDG PET/CT case-control study.

Authors:  Florent L Besson; Hubert de Boysson; Jean-Jacques Parienti; Gérard Bouvard; Boris Bienvenu; Denis Agostini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-09-06       Impact factor: 9.236

Review 4.  Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.

Authors:  Jean Schmidt; Kenneth J Warrington
Journal:  Drugs Aging       Date:  2011-08-01       Impact factor: 3.923

5.  Diagnostic performance of ¹⁸F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis.

Authors:  Florent L Besson; Jean-Jacques Parienti; Boris Bienvenu; John O Prior; Sylvie Costo; Gerard Bouvard; Denis Agostini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-05-11       Impact factor: 9.236

6.  18F-FDG PET versus PET/CT as a diagnostic procedure for clinical suspicion of large vessel vasculitis.

Authors:  Hans Balink; Pieternella M Houtman; James Collins
Journal:  Clin Rheumatol       Date:  2011-06-24       Impact factor: 2.980

7.  FDG PET in the early diagnosis of large-vessel vasculitis.

Authors:  P Sanchez-Roa; John Rees; J Nash; A Chander
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-04-24       Impact factor: 9.236

8.  Assessment of aortitis by semiquantitative analysis of 180-min 18F-FDG PET/CT acquisition images.

Authors:  Isabel Martínez-Rodríguez; N Martínez-Amador; I Banzo; R Quirce; J Jiménez-Bonilla; M De Arcocha-Torres; S Ibáñez-Bravo; C Lavado-Pérez; Z Bravo-Ferrer; R Blanco; M A González-Gay; J M Carril
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-07-24       Impact factor: 9.236

9.  Simple dichotomous assessment of cranial artery inflammation by conventional 18F-FDG PET/CT shows high accuracy for the diagnosis of giant cell arteritis: a case-control study.

Authors:  Berit Dalsgaard Nielsen; Ib Tønder Hansen; Stine Kramer; Ate Haraldsen; Karin Hjorthaug; Trond Velde Bogsrud; June Anita Ejlersen; Lars Bjørn Stolle; Kresten Krarup Keller; Philip Therkildsen; Ellen-Margrethe Hauge; Lars Christian Gormsen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-07-31       Impact factor: 9.236

10.  18 F-Fluorodeoxyglucose-Positron Emission Tomography As an Imaging Biomarker in a Prospective, Longitudinal Cohort of Patients With Large Vessel Vasculitis.

Authors:  Peter C Grayson; Sara Alehashemi; Armin A Bagheri; Ali Cahid Civelek; Thomas R Cupps; Mariana J Kaplan; Ashkan A Malayeri; Peter A Merkel; Elaine Novakovich; David A Bluemke; Mark A Ahlman
Journal:  Arthritis Rheumatol       Date:  2018-02-06       Impact factor: 10.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.